Cefixime 200 mg + Clavulanic Acid 125 mg Film-Coated Tablet

Cefixime 200 mg + Clavulanic Acid 125 mg Film-Coated Tablet is a film-coated tablet formulated with Cefixime 200 mg + Clavulanic Acid 125 mg. The active ingredient profile is Cefixime; Clavulanic Acid, placing the product in the cephalosporin + beta-lactamase inhibitor combination category. Cefixime provides antibacterial activity and clavulanic acid acts as a beta-lactamase inhibitor, a combination intended to help protect the beta-lactam component against certain bacterial resistance enzymes. The film coating provides a finished oral solid-dosage presentation and may help with handling and product acceptability. For website cataloguing, the composition, strength, dosage form and release/coating characteristics should be displayed prominently and consistently. This product is intended for professional pharmaceutical presentation and should not be described using unapproved efficacy, cure or superiority claims. Clinical selection should depend on the patient, diagnosis, susceptibility or symptom profile, and the prescriber’s judgement. Prescription status, contraindications, precautions, interactions, adverse-effect information and dosing must be checked against the current approved label before publication. Manufacturer, licence, storage, shelf-life, pack configuration and market-specific regulatory details should be added only from verified product documentation.